-

60th ASH Annual Meeting & Exposition

The premier event in malignant and non-malignant hematology. 60th ASH Meeting will be in San Diego, CA

 

Oncopeptides will present updated data from two ongoing trials, one Poster session and one Oral Session.

 

POSTER Presentation: ANCHOR
Saturday, December 1, 2018, at 06:15 pm PST
San Diego Convention Center, Hall GH
Session Name: 653. Myeloma: Therapy, Excluding Transplantation: Poster I

 

ORAL Presentation: HORIZON
Monday, December 3, 2018, at 08:15 am PST
San Diego Convention Center, Room  6F
Session Name: 653: Myeloma: Therapy, Excluding Transplantation: Antibodies and Targeted Therapies

Upcoming events

Silent Period

-

Webcast - Oncopeptides rescinds voluntary withdrawal of Pepaxto in the US

09:00 CET

January 21, 2022, Oncopeptides announced that the Company has contacted the US Food and Drug Administration and rescinded the October 22, 2021, letter requesting voluntary withdrawal of the NDA of Pepaxto® in the US. Investors, financial analysts and media are invited to participate in a webcast with a Q&A session on January 24, 2022, at 09:00 (CET).

Year-end report 2021

08:00 CET

Silent Period

-

Silent Period

-